To the Editor:
We read with great interest the article by Grika, et al, a retrospective analysis of the morbidity, mortality, and organ damage in patients with antiphospholipid syndrome (APS), with or without systemic lupus erythematosus (SLE)1. The authors conclude that “APS occurs among young individuals and it is a cause of increased morbidity, with one-fourth of the patients progressing to organ damage in a mean time of 10 years from disease onset”1. Given that the number of studies analyzing the organ damage in patients with APS is limited and that no damage index exists specifically validated for patients who are aPL-positive, the study is timely and important. Our group also has been interested in assessing and quantifying organ damage …
Address correspondence to Dr. Erkan; e-mail: erkanD{at}hss.edu